Activities of Anna ROSBACH related to 2012/2041(INI)
Plenary speeches (1)
Rising threats from antimicrobial resistance (short presentation)
Reports (1)
REPORT on the Microbial Challenge – Rising threats from Antimicrobial Resistance PDF (224 KB) DOC (156 KB)
Amendments (31)
Amendment 1 #
Motion for a resolution
Citation 12
Citation 12
– having regard to the secon3rd revision of the WHO list of critically important antimicrobials for human medicine (rReport of the first3rd meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance [AGISAR], Copenhagen, 2009), 14-17 June 2011, Oslo, Norway), and to the OIE List of Antimicrobial Agents of Veterinary Importance (OIE List, May 2007) and subsequent refinements,
Amendment 23 #
Motion for a resolution
Recital H a (new)
Recital H a (new)
Ha. whereas, despite farmers' primary objective to keep their livestock healthy and productive through good agricultural practices (hygiene, proper feed, appropriate husbandry and good animal management), animals can still become ill, and appropriate therapy and veterinary medicines should be available;
Amendment 29 #
Motion for a resolution
Recital H b (new)
Recital H b (new)
Hb. whereas the use of diagnostics have a vital role to play in combating AMR by encouraging more targeted approaches to treatment;
Amendment 31 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Considers that, while almost all Member States have developed national AMR strategies in accordance with the Council Recommendation on prudent use of antimicrobial agents in human medicine, progress with regard to meeting set objectives has been slow and uneven; calls for firm governmental commitment to full and timely implementation at national level;
Amendment 32 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Welcomes the Commission's five-year strategic Action Plan on tackling AMR, but expresses concern that many of the action points reiterate measures prescribed over a decade earlier in the Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine;
Amendment 35 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Underlines that the key objective of any AMR strategy is to maintain the efficiency of existing antimicrobials by using them responsibly at the correct therapeutic level only when strictly prescribed over a limitedspecific time at the appropriate dosage, and reducing the use of antimicrobials in general and especially of Critically- Important Antimicrobials (CIAs)14 in human and veterinary medicine thereby also taking into account the OIE List of Antimicrobial Agents of Veterinary Importance (OIE List);
Amendment 36 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Underlines that the key objective of any AMR strategy is to maintain the efficiency of existing antimicrobials by using them responsibly at the correct therapeutic level only when strictly prescribed over a limited time at the appropriate dosage, and reducing the use of antimicrobials in general and especially of Critically- Important Antimicrobials (CIAs) in human and veterinary medicine; we need to enhance surveillance of the use of antimicrobials in babies and young children, as well as in clinical treatment, where there is a need to control and measure antimicrobial use;
Amendment 37 #
Motion for a resolution
Paragraph 2 – footnote 14
Paragraph 2 – footnote 14
14. Report of the first3rd meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR), Copenhagen, 2009, 14-17 June 2011, Oslo, Norway.
Amendment 41 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Stresses that more efforts are needed to control the use of antimicrobials in the veterinary sector; strongly disapproves of the uncontrolled prophylactic use of antimicrobials in animal husbandry; controls on, and the criteria for, imports of food from non-Member States should be enhanced, particularly owing to the potential that such imports may contain traces of antimicrobials;
Amendment 45 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Stresses that more efforts are needed to control the use of antimicrobials in the human and veterinary sectormedicine; strongly disapproves of the uncontrolled prophylactic use of antimicrobials in animal husbandry;
Amendment 53 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls on the Commission to come up with a legislative proposal for the veterinary sector to limit the use of third- and fourth-generation CIAs for humans; stresses that any such proposal must be founded on evidence-based European guidelines on the prudent use of antimicrobials in veterinary medicine;
Amendment 63 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Underlines that the increased use of diagnostics is necessary to improve the accuracy of diagnoses, leading to a reduction in the use of antimicrobials;
Amendment 68 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. With a view to limiting the use and easy availability of antimicrobial agents, welcomes Member States’ initiatives to review the legal status of all oral, inhaled and parenteral antibiotics (namely antimalarial, antiviral and antifungal drugs) that remain available to patients without a prescription; antibiotics should not be available in EU Member States without a prescription, i.e. sold freely, as this encourages people to self-treat, often on the basis of inaccurate assumptions;
Amendment 69 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. With a view to limiting the use and easy availability ofinappropriate use and uncontrolled access to antimicrobial agents, welcomes Member States' initiatives to review the legal status of all oral, inhaled and parenteral antibiotics (namelymicrobials (including antimalarial, antiviral and antifungal drugs) that remain available to patients without a prescription;
Amendment 76 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls on the Commission and Member States, in accordance with the competent EU Agencies, to devise and promote prudent use guidelines aimed at reducing non-essential and inappropriate exposure to antimicrobials in human and veterinary medicine, livestock farming, agriculture, aquaculture and horticulture;
Amendment 77 #
Motion for a resolution
Paragraph 9 a (new)
Paragraph 9 a (new)
9a. Welcomes moves by public authorities in the Member States to use vaccination as a key intervention in their AMR strategies but believes this should not replace good farm management and animal husbandry systems;
Amendment 83 #
Motion for a resolution
Paragraph 9 b (new)
Paragraph 9 b (new)
9b. Underlines that infection prevention and control is a vital cornerstone in the fight against AMR in human medicine; believes that research into the epidemiology of healthcare-associated infections (HAIs) due to MRSA and C. difficile and other emerging multidrug resistant organisms needs to be broadened out;
Amendment 85 #
Motion for a resolution
Paragraph 9 c (new)
Paragraph 9 c (new)
9c. Calls on the Commission and Member States to increase the exchange of best practice on preventing and reducing healthcare associated infections (HAIs);
Amendment 92 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Notes the importance of access to rapid, reliable and affordable diagnostic tools in the development of new treatment strategies;
Amendment 95 #
Motion for a resolution
Paragraph 12 b (new)
Paragraph 12 b (new)
12b. Calls on the Commission and Member States to strengthen incentives for public and private sector cooperation to reinvigorate antimicrobial research and development (R&D); believes that sharing knowledge and pooling resources through innovative public-private partnerships (PPPs) will be critical to ensuring the clinical efficacy and availability of existing antimicrobials;
Amendment 96 #
Motion for a resolution
Paragraph 12 c (new)
Paragraph 12 c (new)
12c. Calls on the Commission to ensure that, as part of the EU 2020 strategy, farmers across all EU Member States can have access to smart, effective and alternative tools to cure their animals, including for minor uses and minor species (MUMS), which currently face a substantial lack of veterinary medicines;
Amendment 97 #
Motion for a resolution
Paragraph 12 d (new)
Paragraph 12 d (new)
12d. Calls on the Commission to ensure the development and availability of more on farm tools for early, rapid diagnosis and control of diseases, as well as a broad and effective diagnostic system at Member State level which can ensure the timely delivery of results in case bacteriological examinations are performed;
Amendment 101 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses the importance of establishing an effective European network of national surveillance systems in the human health and veterinary sectors in order to facilitate the compilation of clear, comparable, transparent and timely reference data on antimicrobial drug usage; believes this should be based on the existing monitoring networks operated by EFSA, the ECDC European Surveillance of Antimicrobial Consumption Network (ESAC-nNet), the ECDC European Antimicrobial Resistance Surveillance Network (EARS-nNet), the ECDC Food- and Waterborne Disease Network (FWD-Net), and the EMA European Surveillance of Veterinary Antimicrobial Consumption (ESVAC);
Amendment 103 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses the importance of establishing an effective European network of national surveillance systems in the human health and veterinary sectors, based on uniform standards for all Member States, in order to facilitate the compilation of clear, comparable, transparent and timely reference data on antimicrobial drug usage; believes this should be based on the existing monitoring networks operated by EFSA, the ECDC European Surveillance of Antimicrobial Consumption Network (ESAC-net), the ECDC European Antimicrobial Resistance Surveillance Network (EARS-net), and the EMA European Surveillance of Veterinary Antimicrobial Consumption (ESVAC);
Amendment 105 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14a. Calls on Member States to promote closer inter-sectoral collaboration between relevant authorities and sectors to encourage a more integrated veterinary-human health approach and monitor the implementation of national antimicrobial resistance strategies;
Amendment 108 #
Motion for a resolution
Paragraph 14 b (new)
Paragraph 14 b (new)
14b. Calls on the Commission and Member States to ensure that future measuring and reporting on the use of antimicrobials in both the human and veterinary sectors will be broadened out, showing not only the total amount of antimicrobials used but also types of antimicrobials, treatment times, etc.;
Amendment 110 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Notes that the encouragement of appropriate antimicrobial use depends on a change of attitude and practice among patients, farmers and, medical doctors, veterinarians and other practitioners in the spheres of human and veterinary and human medicine; considers that more effective and continuous educational and training measures should be taken at both national and European level;
Amendment 113 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Notes that the encouragement of appropriate antimicrobial use depends on a change of attitude and, practice and education among patients, farmers and practitioners in the spheres of veterinary and human medicine; considers that more effective and continuous educational and training measures should be taken at both national and European level;
Amendment 116 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Welcomes the annual European Antibiotic Awareness Day (18 November) instituted to promote the responsible use of antimicrobials; considers, however, that its visibility and potential could be more effectively maximised through strengthened political support at national and European levels, a broader approach which covers also animals, and coordinated, innovative and high-impact campaigns based on the experience derived from successful European and international initiatives;
Amendment 122 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Calls on the Commission to build on the work of the TATFAR and promote similar multilateral and bilateral commitments for the prevention and control of AMR with other global partners;
Amendment 124 #
Motion for a resolution
Paragraph 20 a (new)
Paragraph 20 a (new)
20a. Urges Member States and the Commission to encourage and promote global risk management initiatives, such as the WHO list of CIAs for human medicine and the OIE List of Antimicrobials of Veterinary Importance;